Health Trials

Rheumatoid Arthritis Associated Interstitial Lung Disease (RA-ILD)

1

Review clinical trials related to Rheumatoid Arthritis Associated Interstitial Lung Disease (RA-ILD). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic Profile of Genakumab Injection in Patients With Connective Tissue Disease-associated Interstitial Lung Disease

This study was conducted in a randomized, double-blind, placebo-controlled design to evaluate the efficacy and safety of Genakumab injection in the treatment of CTD-ILD including Rheumatoid Arthritis associated Interstitial Lung Disease (RA-ILD) and Systemic Sclerosis associated Interstitial Lung Disease (SSc-ILD)

Participants needed: 30
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Changchun GeneScience Pharmaceutical Co., Ltd.Updated: Jan 17, 2025Locations: 4
Eligibility criteria

Those who voluntarily sign informed consent and can complete the experiment acco... [+7]

Allergic to experimental drugs or biological agents; People who have previously... [+30]

Read more